Youssef MA

No ORCID on file · 13 papers in corpus
guideline 2020
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deaa241

STUDY QUESTION: Can a core outcome set to standardize outcome selection, collection and reporting across future infertility research be developed? SUMMARY ANSWER: A minimum data set, known as a core outcome set, has been developed for rand…

observational 2020
Journal of ovarian research ·doi:10.1186/s13048-020-00665-0

BACKGROUND: The aim of this study was to determine whether the treatment with doxycycline before and after oocyte retrieval is as effective as salpingectomy in minimizing the detrimental effect of hydrosalpinx on the outcomes of IVF-ET. ME…

meta-analysis 2020
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deaa243

STUDY QUESTION: Can consensus definitions for the core outcome set for infertility be identified in order to recommend a standardized approach to reporting? SUMMARY ANSWER: Consensus definitions for individual core outcomes, contextual sta…

guideline 2020
Human Reproduction ·doi:10.1093/humrep/deaa242

STUDY QUESTION: Can the priorities for future research in infertility be identified? SUMMARY ANSWER: The top 10 research priorities for the four areas of male infertility, female and unexplained infertility, medically assisted reproduction…

review 2018
Human reproduction open ·doi:10.1093/hropen/hoy007

STUDY QUESTIONS: We aim to produce, disseminate and implement a core outcome set for future infertility research. WHAT IS KNOWN ALREADY: Randomized controlled trials (RCTs) evaluating infertility treatments have reported many different out…

rct 2016
Journal of ovarian research ·doi:10.1186/s13048-016-0237-8

BACKGROUND: The aim of this study was to compare the efficacy of antagonist rescue protocol (replacing GnRH agonist with GnRH antagonist and reducing the dose of gonadotropins) combined with cabergoline versus cabergoline alone in the preve…

meta-analysis 2016
The Cochrane database of systematic reviews ·doi:10.1002/14651858.cd001750.pub4

BACKGROUND: Gonadotrophin-releasing hormone (GnRH) antagonists can be used to prevent a luteinizing hormone (LH) surge during controlled ovarian hyperstimulation (COH) without the hypo-oestrogenic side-effects, flare-up, or long down-regula…

meta-analysis 2016
The Cochrane database of systematic reviews ·doi:10.1002/14651858.cd003719.pub4

BACKGROUND: For the last few decades urinary human chorionic gonadotrophin (uhCG) has been used to trigger final oocyte maturation in cycles of in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Recombinant technology…

review 2015
Journal of Advanced Research ·doi:10.1016/j.jare.2015.01.005

Final oocyte maturation in GnRH antagonist co-treated IVF/ICSI cycles can be triggered with HCG or a GnRH agonist. We conducted a systematic review and meta-analysis of randomized controlled trials to evaluate the efficacy and safety of the…

observational 2015
BMC women's health ·doi:10.1186/s12905-015-0228-8

BACKGROUND: To our knowledge, no large population - based studies have been performed on the topic of menstrual patterns among Egyptian adolescent in recent years. The aims of this study were to identify menstrual patterns and associated di…

observational 2015
BMC women's health ·doi:10.1186/s12905-015-0202-5

BACKGROUND: To study the prevalence of Chlamydia infection in women with primary and secondary unexplained infertility using ELISA technique for antibody detection and real time, fully automated PCR for antigen detection and to explore its …

rct 2014
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2014.02.001

OBJECTIVE: Follicular fluid of mature oocytes is rich in growth factors and cytokines that may exert paracrine and autocrine effects on implantation. The aim of this study was to investigate if flushing the endometrial cavity with follicula…

meta-analysis 2014
The Cochrane database of systematic reviews ·doi:10.1002/14651858.cd008046.pub4

BACKGROUND: Human chorionic gonadotropin (HCG) is routinely used for final oocyte maturation triggering in in vitro fertilisation (IVF)/intracytoplasmic sperm injection (ICSI) cycles, but the use of HCG for this purpose may have drawbacks. …